Nucleoside analogue activators of cyclic AMP-independent protein kinase A of Trypanosoma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2041-1723

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Nucleoside analogue activators of cyclic AMP-independent protein kinase A of Trypanosoma ; volume:10 ; number:1 ; day:29 ; month:3 ; year:2019 ; pages:1-14 ; date:12.2019
Nature Communications ; 10, Heft 1 (29.3.2019), 1-14, 12.2019

Classification: Naturwissenschaften

Creator: Bachmaier, Sabine
Volpato Santos, Yuri
Kramer, Susanne
Githure, George Boniface
Klöckner, Thomas
Pepperl, Julia
Baums, Cordula
Schenk, Robin
Schwede, Frank
Genieser, Hans-Gottfried
Dupuy, Jean-William
Forné, Ignasi
Imhof, Axel
Basquin, Jerôme
Lorentzen, Esben
Boshart, Michael

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41467-019-09338-z

URN: urn:nbn:de:101:1-2019041621323201147349

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:51 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bachmaier, Sabine
Volpato Santos, Yuri
Kramer, Susanne
Githure, George Boniface
Klöckner, Thomas
Pepperl, Julia
Baums, Cordula
Schenk, Robin
Schwede, Frank
Genieser, Hans-Gottfried
Dupuy, Jean-William
Forné, Ignasi
Imhof, Axel
Basquin, Jerôme
Lorentzen, Esben
Boshart, Michael
SpringerLink (Online service)

Other Objects (12)

Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue

Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

AMP ed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment

Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia

Treatment with Cyclic AMP Activators Reduces Glioblastoma Growth and Invasion as Assessed by Two-Photon Microscopy

Uridine supplementation with Mitocnol antagonizes antiretroviral nucleoside analogue-induced mitochondrial peripheral and cerebral neuropathy in vivo

An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations

The esogetic crystal activators

Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue

Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

AMP ed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment

Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia

Treatment with Cyclic AMP Activators Reduces Glioblastoma Growth and Invasion as Assessed by Two-Photon Microscopy

Uridine supplementation with Mitocnol antagonizes antiretroviral nucleoside analogue-induced mitochondrial peripheral and cerebral neuropathy in vivo

An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations

The esogetic crystal activators

Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue

Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

AMP ed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment

Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia

Treatment with Cyclic AMP Activators Reduces Glioblastoma Growth and Invasion as Assessed by Two-Photon Microscopy

Uridine supplementation with Mitocnol antagonizes antiretroviral nucleoside analogue-induced mitochondrial peripheral and cerebral neuropathy in vivo

An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations

The esogetic crystal activators

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Nucleoside analogue activators of cyclic AMP-independent protein kinase A of Trypanosoma

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue

Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

AMP ed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment

Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia

Treatment with Cyclic AMP Activators Reduces Glioblastoma Growth and Invasion as Assessed by Two-Photon Microscopy

Uridine supplementation with Mitocnol antagonizes antiretroviral nucleoside analogue-induced mitochondrial peripheral and cerebral neuropathy in vivo

An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations

The esogetic crystal activators

Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue

Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

AMP ed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment

Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia

Treatment with Cyclic AMP Activators Reduces Glioblastoma Growth and Invasion as Assessed by Two-Photon Microscopy

Uridine supplementation with Mitocnol antagonizes antiretroviral nucleoside analogue-induced mitochondrial peripheral and cerebral neuropathy in vivo

An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations

The esogetic crystal activators

Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue

Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

AMP ed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment

Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia

Treatment with Cyclic AMP Activators Reduces Glioblastoma Growth and Invasion as Assessed by Two-Photon Microscopy

Uridine supplementation with Mitocnol antagonizes antiretroviral nucleoside analogue-induced mitochondrial peripheral and cerebral neuropathy in vivo

An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations

The esogetic crystal activators

Related objects

Reset password